Effect of supplementation in treatment of gestational diabetes
Not Applicable
- Conditions
- Gestational diabetes.Diabetes mellitus in pregnancy, unspecifiedO24.9
- Registration Number
- IRCT201406305623N20
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 54
Inclusion Criteria
Pregnant women aged 18-40 years diagnosed with GDM at 24-28 weeks' gestation
Exclusion Criteria
Pre-existing diabetes
Required complex diets
Chronic medical conditions
Significant psychiatric disease
Smokers
Kidney or liver diseases
Chronic hypertension
Hypothyroidism
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Infants' weight. Timepoint: Delivery time. Method of measurement: Scale.;Infants' head circumference. Timepoint: Delivery time. Method of measurement: Tape.;Newborns' length. Timepoint: Delivery time. Method of measurement: Tape.;Polyhydramnios. Timepoint: After the intervention. Method of measurement: Sonography.;Newborn's bilirubin. Timepoint: Delivery time. Method of measurement: Enzymatic kit.;Apgar score. Timepoint: Delivery time. Method of measurement: Clinical observation.;Preterm delivery. Timepoint: After delivery. Method of measurement: Medical record.;Maternal pre-eclampsia. Timepoint: After delivery. Method of measurement: Medical record.;Maternal hospitalization. Timepoint: After delivery. Method of measurement: Medical record.
- Secondary Outcome Measures
Name Time Method Hs-CRP. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: ELISA kit.;Nitric oxide. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Spectrophotometry.;Total antioxidant. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Spectrophotometry.;Malondialdehyde. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Spectrophotometry.;Glutathione. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Spectrophotometry.